Armistice Capital, LLC 13D/13G Filings for Neuphoria Therapeutics Inc. (NEUP)

Armistice Capital, LLC 13D and 13G filings for Neuphoria Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
5:06 pm
Purchase
2024-12-31 13G Neuphoria Therapeutics Inc.
NEUP
Armistice Capital, LLC 1,033,796
4.990%
1,033,796increase
(New Position)
Filing